Skip to main content
Download PDF

Obesity as a clinical predictor for severe manifestation of dengue: a systematic review and meta-analysis

BMC Infectious Diseases volume 23, Article number: 502 (2023) Cite this article

Abstract

Background

Severe dengue often leads to poor clinical outcomes and high mortality; as a result, it is of vital importance to find prognostic factors associated with the severe form of dengue. Obesity is known to deteriorate many infectious diseases due to impaired immune responses. Several studies have suggested that obese patients with dengue infection tend to have more severe manifestations with poorer prognosis. However, a firm conclusion could not be drawn due to the varied results of these studies. Here, we aimed to conduct a systematic review and meta-analysis to investigate the association between obesity and dengue severity.

Methods

A literature search for relevant studies was conducted in PubMed, Embase, Ovid Medline and Cochrane from inception to September 9, 2022. The two main keywords were “dengue” and “obesity”. Mantel-Haenszel method and random effects model was used to analyze the pooled odds ratio with 95% confidence intervals.

Results

A total of 15 article involving a total of 6,508 patients were included in the meta-analysis. Included patients in most studies were hospitalized pediatric patients. Only one study included adulthood data. Three cohort studies, four case-control studies, and one cross-sectional studies found a significant association between obesity and dengue severity. In contrast, three cohort studies, three case-control studies, and one cross-sectional study reported no significant relationship between obesity and dengue severity. Our analysis results showed that patient with obesity is 50% (OR = 1.50; 95%CI: 1.15–1.97) more likely to develop severe manifestation of dengue.

Conclusion

This meta-analysis revealed that overweight could be a clinical predictor for severe disease for pediatric patients with dengue infection.

Peer Review reports

Background

Dengue fever is one of the most common arthropod-borne diseases around the globe [1, 2]. The disease is transmitted by vectors such as Aedes aegypti carrying dengue virus (DENV). It is estimated there are 390 million dengue infections around the world yearly [1]. In Taiwan, the burden of dengue was substantial, resulting in an annual loss of 115.3 disability-adjusted life-years (DALYs) per million population. The economic costs associated with dengue were primarily attributed to hospitalization expenses and the loss of productivity due to deaths occurring during epidemic years [3].

Most dengue-infected patients present with asymptomatic or inapparent infections[4]. According to previous literature, only a quarter of the dengue-infected patients will have primarily self-limiting symptoms [2]. The vexing part about a dengue endemic, however, is that a portion of the asymptomatic patients will develop severe dengue or even dengue shock as the disease progresses. Those with these conditions will have a horrendously high case fatality rate of 12–44% [5]. Luckily, with appropriate supportive management, such as intravenous fluid therapy, the mortality rate for dengue patients can be suppressed to less than 1%. Therefore, the importance to develop a clinical predictor for dengue patients during the time of an endemic is imperative [6, 7].

Overweight and morbid obesity (MO) are conditions considered to be prevalent among developed and developing countries. Although modern medicine has confirmed that obesity will have a negative impact on infectious diseases, such as coronavirus disease 2019 (COVID-19) [8], its role in dengue infection remains debated, possibly due to the heterogenicity of obesity definition [9, 10]. Previous related literature often based their data collected from different regions with different criteria for the overweight group and normal-weight group.

Obesity will elicit several negative physiological changes, including immune, respiratory, and circulatory systems. It is not only a risk factor for countless morbidities but also considered to be a negative prognostic factor for multiple infectious diseases [11,12,13]. The impaired immunity causes the obese patient to have a higher rate of post-surgery infection [14, 15] and a higher chance of getting severe viral infections like coxsackievirus, encephalomyocarditis virus, Influenza A, virus and SARS-CoV-2 [16,17,18,19,20].

Several biomarkers have been identified and proved effective in predicting the course of the disease in the past [21,22,23]. This systematic review and meta-analysis aimed to identify the relationship between dengue development and nutritional status, especially obesity, to investigate whether it can predict dengue prognosis.

Methods

This systematic review and meta-analysis was conducted adhering to the principles described in the Cochrane Handbook [24] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement [25]. As this study was a review of previously published studies, ethical approval or patient consent was waived.

Information sources and search strategy

PubMed, Embase, Ovid Medline, and Cochrane were searched from inception to September 9, 2022, for relevant studies. We utilized the Patient, Investigated condition, Comparison condition, and Outcome (PICO) format to structure our review question: “In a patient with dengue, will the nutritional status become an effective clinical predictor for potential severe dengue?“ Accordingly, the patient population was defined as “patients infected with dengue.“ The investigated condition focused on “overweight patients,“ while the comparison condition involved “patients with healthy weights.“ Our primary outcome of interest was the “dengue prognosis.“

We used Boolean logic operator ‘AND’ to organize our two main keywords “dengue” and “obesity” into free text terms. Other synonyms were also included by using ‘OR’. A detailed list of free text terms of the search strategy is provided in Additional file 1. No filter or limit is used during the search. The search was complemented with hand searching of the reference lists of relevant studies.

Eligibility criteria

This systematic review includes all observational and interventional studies that aim to compare the clinical development in dengue patients with different nutritional statuses, especially obesity. In vitro and animal studies, case reports, case series, reviews, letters, and conference abstracts were excluded.

Outcome measure

In this study, we hope to assess whether obese patients tend to develop severe dengue. As a result, we focused on the one major clinical outcome of dengue infection that will differentiate dengue patient from mild infection: the development of severe manifestation of dengue. Due to the change in severity classification of dengue in 2009, we categorize the primary outcome according to the two different World Health Organization (WHO) criteria (Table 1).

Table 1 Outcome measurements of the present study. D, dengue; DF, dengue fever; WS, warning sign; SD, severe dengue; DHF, dengue hemorrhagic fever; WS, warning sign; DSS, dengue shock syndrome
Full size table

Collection process

Database search, title and abstract screening, full-text evaluation, data extraction, and meta-analysis were performed. Records were exported into EndNote 20 for duplicate removal, sorting, and further screening. The basic characteristics of the studies including author, year of the study and, article type were documented on a form using Microsoft Word 2019 to identify the studies. Inclusion criteria of the study population, dengue diagnostic criteria used and numbers of mild and severe dengue in patients with various weight categories were extracted as outcome. Missing data was either sought from other systematic review [26] or excluded from the study, no computed data was made.

Statistical analysis

Review manager 5.4.1 was used to generate the forest plots, heterogeneity, and effect estimation using Odds Ratio (OR). Mantel-Haenszel method and random effects model was used. We considered p < 0.05 as a statistically significant differences while the confidence interval was set to be 95%.

Bias assessment

Risk of bias assessment of the included records was evaluated using Newcastle-Ottawa Scale (NOS) while cross sectional study was evaluated by modified NOS suggested by Modesti et al. [27]. Standard NOS contains 3 domains and a total score of 9 (Table 2). A score of 7 or more defines a high quality records. A score of 5 or more defines a fair quality record while less defines a poor quality record [28, 29]. Publication bias was assessed by a funnel plot using Review manager.

Table 2 Quality rating in Newcastle-Ottawa Scale [29]
Full size table

Statistical analysis

We synthesized the data using the criteria of dengue severity mainly due to the massive heterogeneity in the definitions of overweight and obesity among all the included studies. We synthesized 15 records into the development of severe manifestation of dengue analysis. We obtained funnel plots to assess publication bias in the analysis.

A subgroup analysis was performed to reduce heterogeneity by annihilating potential bias that different study designs might cause; we divided our included study into three categories: cohort, case-control, and cross-sectional.

We also performed an additional analysis by combining data from multiple studies that used a common, yet different cutoff point.

Results

Study selection

A total of 2,034 reports were identified from electronic database search and six records were found from two systematic reviews [26, 30]. Among them, 658 records were removed manually by authors and automatically by EndNote due to duplication. Out of the 1,376 records included for abstract screening, we excluded 1,340 records. With seven records identified from the citation search, we have 42 full texts retrieved in total to determine eligibility. In the 27 excluded records, we have 10 poster abstracts removed, five reports failed to match our outcome of interest, four records did not specify their crude data and three records focus on malnutrition patients and not specifying obesity data. We also excluded five studies that, while relevant to our desired outcome, utilized different cutoff points for defining dengue severity compared to the other included studies (Fig. 1).

Fig. 1
figure 1

PRISMA 2020 flow chart of record acquisition

Full size image

Characteristics of included studies

The main characteristics of included studies are summarized in Table 3. Of these fifteen studies, six were cohort studies (40.0%) [31,32,33,34,35,36], seven were case-control studies (46.7%) [37,38,39,40,41,42,43], and two were cross-sectional studies (13.3%) [44, 45]. A total of 6,508 patients were analyzed, with inclusion criteria starting from age 0 to the highest observed age of 73 year-old. The patients included in most studies were hospitalized pediatric patients. Only one study included adulthood data [36], and one study listed outpatient patients into population for analysis [45]. twelve studies applied the WHO 1997 classification for dengue severity. Included studies were conducted from 1995 to 2020 in endemic areas of Asia (Thailand, [32, 38, 40, 42, 45] Indonesia, [31, 33, 34, 37, 39, 41, 43, 44] Malaysia [36]) and Latin America (Paraguay [35]).

Table 3 Main characteristics of included studies
Full size table

The overweight or obese status was defined using body weight or body weight-for-age in five studies [32, 34, 38, 40, 42]; body mass index (BMI) or BMI-for-age in four studies [36, 39, 43, 45] and weight/height% in one study [37]. Other five studies did not specify the criteria for obesity [31, 33, 35, 41, 44]. Confirmatory diagnosis of dengue was performed by laboratory tests, such as serology for anti-dengue IgM and/or IgG (12/15, 80.0%) [31,32,33,34,35, 37, 38, 41,42,43,44,45] dengue nonstructural protein 1 (NS1) antigen test (3/15, 20.0%) [35, 36, 45], identification of viral ribonucleic acid (RNA) using polymerase chain reaction (PCR) (4/15, 26.7%) [34, 35, 38, 40], and isolation of viruses (1/15, 6.7%) [38]. The majority of studies employed multiple diagnostic assays to confirm the diagnosis of dengue, except for one study that did not specify the method used [39]. Warning signs or symptoms were reported as follows: skin bleeding (petechiae, purpura, hematoma) (9/15, 60.0%) [31,32,33, 35, 37, 38, 41, 42, 44], epistaxis (4/15, 26.7%) [31,32,33, 41], hematemesis (3/15, 20.0%) [31,32,33], melena (3/15, 20.0%) [31,32,33], hepatomegaly (7/15, 46.7%) [33, 34, 37, 38, 41, 42, 44], abdominal pain (8/15, 53.4%) [33,34,35,36,37,38, 41, 42], vomiting and nausea (8/15, 53.4%) [33,34,35,36,37,38, 41, 42], diarrhea (4/15, 26.7%) [33, 36, 42, 44], thrombocytopenia (4/15, 26.7%) [33, 36, 37, 44], seizure (1/15, 6.7%) [33], bleeding gums (1/15, 6.7%) [32], pleural effusion (3/15, 20.0%) [33, 42, 44], ascites (1/15, 6.7%) [42], menorrhagia (1/15, 6.7%) [32] shock (1/15, 6.7%) [33], hemoconcentration (1/15, 6.7%) [33] and altered consciousness (1/15, 6.7%) [33].

Most of the studies classify dengue patients using the 1997 criteria of dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). Except two studies using 2009 WHO criteria [35, 36] and one study uses 1986 WHO criteria [32]. Most of the population included are diagnosed with DHF across all four stages.

Obesity as a clinical predictor of development of severe manifestation of dengue

Overweight patients are 50% (OR 1.50, 95% CI 1.15–1.97) more likely to develop severe manifestation of dengue when compared to patients with normal weights. (Fig. 2). The result is statistically significant but with high heterogenicity (I2 = 48%, p = 0.02). In the subgroup analysis, only the studies with case-control design achieved statistical significance (OR 1.90, 95% CI 1.20–2.99) but even with a higher heterogenicity (I2 = 76%, p = 0.0003). The other two subgroups failed to demonstrate statistical significance but with lower heterogenicity.

Fig. 2
figure 2

Development of DSS/SD comparison between over- and normal-weight patients

Full size image

We conducted a second analysis that including only hospitalized pediatric patients diagnosed with DHF by excluding records that included population diagnosed with DF (Fig. 3). However, we observed a finding similar to not excluding patients diagnosed with DF. In pediatric hospitalized patients diagnosed with DHF, overweight children are 59% (OR 1.59, 95% CI 1.09–2.31) more likely to develop shock signs. However, this result has an even higher heterogenicity (I2 = 64%, p = 0.003). In the subgroup analysis, only the studies with case-control design demonstrated statistical significance (OR 1.85, 95% CI 1.14–3.01) and a higher heterogenicity (I2 = 78%, p = 0.0003).

Fig. 3
figure 3

Events of DHF and DSS comparison between over- and normal-weight patients

Full size image

We conducted an additional analysis and found obesity patients have a statistically significant 16% increase in the development of dengue with concerning conditions. The concerning conditions are defined by patient with a final diagnosis across all four stages of DHF, dengue with warning signs and severe dengue. Further details about this analysis can be found in the supplementary materials (Additional file 2) accompanying our report.

Risk of bias assessment

Publication bias of the analysis was not significant since we found both funnel plots represent approximate symmetrical shapes (Fig. 4 and Fig. 5).

Fig. 4
figure 4

Funnel plot of Fig. 2 Development of DSS/SD comparison

Full size image
Fig. 5
figure 5

Funnel plot of Fig. 3 Events of DHF and DSS comparison

Full size image

Out of the 15 of studies evaluated, nine were classified as high-quality studies, while six were determined to be of fair quality.(Table 4) In terms of case-control studies, most of them scored 3 stars in the selection category [37,38,39,40, 42, 43], as they predominantly employed hospitalized patients as control. Majority of the studies did not receive any stars in the comparability category, indicating a lack of controlled factors. However, two studies did address variables related to obesity, such as comorbidity, age[36, 46], and dengue virus types [40], which contributed to enhancing the comparability of their findings. It is worth noticing that cross-sectional studies have to use modified NOS with a total score of 10. For a more detailed breakdown of the scoring, please refer to Additional file 3.

Table 4 Results of Newcastle Ottawa-score
Full size table

Discussion

In this systematic review and meta-analysis, we found that obese patients were more likely to develop severe manifestation of dengue as manifested by dengue shock syndrome and severe dengue as compared with normal-weight patients. We showed that obesity is significantly associated with dengue severity. Thus, obesity could be a potential clinical predictor for severe dengue.

The heterogenicity in the dengue-type classification caused difficulties in defining a patient’s clinical conditions. In 1997 [47], WHO published a standard to classify dengue infection severity. In this standard, dengue disease was divided into three types based on the clinical presentations: mild DF, which is associated with self-limited disease; DHF, associated with vascular alterations including thrombocytopenia and granulocytopenia, as well as hepatomegaly; and DSS if systemic plasma leakage occurs. Yet, this classification method was considered to be underestimating the clinical burden of dengue fever due to the fact that some of the severe dengue patients did not match the clinical criteria of plasma leakage [48, 49]. Those patients who did not show significant bleeding did not receive the appropriate medical attention they needed [50, 51]. In 2009 [4], WHO revised the dengue severity level standard and thus regrouped the patients into Dengue and Severe dengue. In the patients classified as dengue, WHO further defines some worrying clinical presentations as warning signs. Those patients who present with warning signs are more likely to develop severe dengue and thus need more intensive care. In this study, we tried to eliminate this heterogenicity by designing a primary outcome focused on the presence of plasma leakage or shock (Fig. 6). Patients with plasma leakage are more likely to develop severe dengue and those who are in shock are in an abysmal condition.

Fig. 6
figure 6

Suggested dengue case classification and levels of severity (adopted from WHO [4])

Full size image

Obesity is a risk factor for various infectious diseases [13]. Obesity-related susceptibility to infectious diseases is believed to be associated with an impairment of both innate and adaptive immune responses and vitamin D deficiency [8]. However, whether obesity is a risk factor or prognostic factor for severe dengue remains elusive. In a meta-analysis study by Tsheten et al., [52] the authors declared that obesity was not significantly associated with severe dengue disease. Nevertheless, in another meta-analysis study by Lima et al. [53], the authors showed that circulating total-cholesterol and low-density lipoprotein (LDL)‐cholesterol levels were inversely and significantly correlated with dengue severity, and suggested that the two factors can serve as routine markers for dengue severity. Indeed, nutritional status may post a significant impact on dengue infection. In an animal experiment, obesity will alter the cytokine change in dengue-infected mice. They also suffered from weight loss and thrombocytopenia compared to mice with a healthy weight [54]. In patients with dengue fever, obese patients tend to have comorbid acute kidney injury [24, 55].

According to Gallagher et al., [56] there are four main key mechanisms on how obesity may affect dengue infection. First, obesity will cause downregulation of AMP-Protein Kinase (AMPK) and thus buildup of lipids at the endoplasmic reticulum that favors viral replication. Second, an increase in adipokines production will lead to chronic inflammation, causing the C-reactive protein (CRP) elevation and imbalance of pro- and anti-inflammatory cytokines. They will further exacerbate the development of plasma leakage through dysfunction of endothelial and platelet. Third, adipokines can trigger downregulation of endothelial nitric oxide synthase (eNOS) and thus accrue the production of reactive oxygen species (ROS), which leads to the damage of the endothelial glycocalyx. Finally, the immunomodulation effect of obesity itself attenuates natural killer cells, B cells, and T cells responses to infection, boosting the inclination toward stronger cytokine pro-inflammatory response.

Compared to previous literature [26, 30], we have added three new articles [36, 39, 45] after 2018 into our analysis. We also attempted to reduce the heterogeneity of the definition of the population through measures like synthesis analysis pool based on population characteristics. We also intentionally excluded the malnourished population in one study [38] due to the ambiguous effects of malnutrition status on dengue infection.

Limitation

This review has several limitations. First, most of the included population are hospitalized patients, which might have a different clinical care status and disease course from patients in the outpatient department. Considering that a majority of dengue patients presented with mild symptoms and did not require hospitalization, the results should be interpreted with caution. Second, the heterogeneity in this study is high. This may be due to the massive differences in classifying a patient as overweight from study to study. Due to the lack of original data, we did not make any adjustments or correlations to address this heterogenicity. It is also worth noting that in some included studies, the specific definition of obesity was not provided. Third, multiple factors, such as previous dengue infection, co-morbidities, or socioeconomic status might also affect a patient clinical status. According to Zulkipli et al. [26] obesity is associated with higher socioeconomic status, which may alter the medical-seeking behavior of individual patients. We did not take any measures to address this issue, and it should be taken into consideration. Lastly, this analysis is based on the final clinical diagnosis given by included data and may not be a complete presentation of the general patient population. Other factors such as end organ (s) failure, respiratory distress, co-morbidity, co-infections, and various other causes might contribute to the final presentation of the patient.

Conclusions

In this study, we demonstrated that obesity can serve as a clinical predictor for patients with an unfavorable outcome of dengue infection. We found 50% more likely the development into severe manifestation of dengue infection for the overweight patients diagnosed with dengue. However, this result should be implemented into clinical practice with great caution since the heterogenicity of this study is high and the study population is limited.

Data Availability

All data generated or analysed during this study are included in this published article.

Abbreviations

AMPK:

AMP-Protein Kinase

BMI:

body mass index

COVID-19:

coronavirus disease 2019

CRP:

C-reactive protein

DENV:

dengue virus

DF:

dengue fever

DHF:

dengue hemorrhagic fever

DSS:

dengue shock syndrome

LDL:

low-density lipoprotein

NS1:

nonstructural protein 1

eNOS:

endothelial nitric oxide synthase

MO:

morbid obesity

NOS:

Newcastle-Ottawa Scale

PCR:

polymerase chain reaction

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

ROS:

reactive oxygen species

RNA:

ribonucleic acid

WHO:

World Health Organization

References

  1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue Lancet. 2019;393(10169):350–63.

    Article  PubMed  Google Scholar 

  3. Luh D-L, Liu C-C, Luo Y-R, Chen S-C. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan. J Infect Public Health. 2018;11(2):215–23.

    Article  PubMed  Google Scholar 

  4. In. Dengue: guidelines for diagnosis, treatment, Prevention and Control: New Edition. Edn. Geneva: World Health Organization; 2009.

    Google Scholar 

  5. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998;352(9132):971–7.

    Article  CAS  PubMed  Google Scholar 

  6. Simmons CP, Farrar JJ, Nguyen v V, Wills B. Dengue. The New England. J Med. 2012;366(15):1423–32.

    CAS  Google Scholar 

  7. Medagama A, Dalugama C, Meiyalakan G, Lakmali D. Risk Factors Associated with Fatal Dengue Hemorrhagic Fever in Adults: A Case Control Study. Canadian Journal of Infectious Diseases and Medical Microbiology 2020, 2020:1042976.

  8. Pugliese G, Liccardi A, Graziadio C, Barrea L, Muscogiuri G, Colao A. Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. Int J Obes. 2022;46(3):449–65.

    Article  CAS  Google Scholar 

  9. Huy NT, Giang TV, Kikuchi M, Zamora J, Hirayama K. Risk factors for dengue shock syndrome: a systematic review and meta-analysis. Am J Trop Med Hyg. 2011;85(6):155.

    Google Scholar 

  10. Zulkipli MS, Rampal S, Bulgiba A, Peramalah D, Jamil NA, See LLC, Zaki RA, Omar SFS, Dahlui M. Is there any association between body mass index and severity of dengue infection? Trans R Soc Trop Med Hyg. 2021;115(7):764–71.

    Article  PubMed  Google Scholar 

  11. Kyrou I, Randeva HS, Tsigos C, Kaltsas G, Weickert MO. Clinical Problems Caused by Obesity. In: Endotext. edn. Edited by Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Grossman A, Hershman JM, Hofland J South Dartmouth (MA); 2000.

  12. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev. 2001;2(2):131–40.

    Article  CAS  PubMed  Google Scholar 

  13. Huttunen R, Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes. 2013;37(3):333–40.

    Article  CAS  Google Scholar 

  14. Torres L, Martins VD, Faria AMC, Maioli TU. The intriguing relationship between obesity and infection. J Infectiology 2018, 1(1).

  15. Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev. 2015;16(12):1017–29.

    Article  CAS  PubMed  Google Scholar 

  16. Karlsson EA, Beck MA. The burden of obesity on infectious disease. Experimental Biology and Medicine. 2010;235(12):1412–24.

    Article  CAS  PubMed  Google Scholar 

  17. Suki M, Leibovici Weissman Y, Boltin D, Itskoviz D, Tsadok Perets T, Comaneshter D, Cohen A, Niv Y, Dotan I, Leibovitzh H, et al. Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study. Eur J Gastroenterol Hepatol. 2018;30(2):143–8.

    Article  PubMed  Google Scholar 

  18. Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metabol. 2021;33(3):479–98.

    Article  CAS  Google Scholar 

  19. Huttunen R, Syrjanen J. Obesity and the outcome of infection. Lancet Infect Dis. 2010;10(7):442–3.

    Article  PubMed  Google Scholar 

  20. Koethe JR, Hulgan T, Niswender K. Adipose tissue and immune function: a review of evidence relevant to HIV infection. J Infect Dis. 2013;208(8):1194–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Constantine GR, Rajapakse S, Ranasinghe P, Parththipan B, Jayawardana P, Wijewickrama A. Hypocalcemia is associated with disease severity in patients with dengue. J Infect Developing Ctries. 2014;8(9):1205–9.

    Article  Google Scholar 

  22. Lin CY, Kolliopoulos C, Huang CH, Tenhunen J, Heldin CH, Chen YH, Heldin P. High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity. Ebiomedicine. 2019;48:425–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Rathore AP, Farouk FS. St. John AL: risk factors and biomarkers of severe dengue. Curr Opin Virol. 2020;43:1–8.

    Article  CAS  PubMed  Google Scholar 

  24. Diptyanusa A, Phumratanaprapin W, Phonrat B, Poovorawan K, Hanboonkunupakarn B, Sriboonvorakul N, Thisyakorn U. Characteristics and associated factors of acute kidney injury among adult dengue patients: a retrospective single-center study. PLoS ONE. 2019;14(1):e0210360.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zulkipli MS, Dahlui M, Jamil Na, Peramalah D, Wai HVC, Bulgiba A, Rampal S. The association between obesity and dengue severity among pediatric patients: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12(2):e0006263.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, Perruolo E, Parati G. Settings ESHWGoCRiLR: panethnic differences in blood pressure in Europe: a systematic review and Meta-analysis. PLoS ONE. 2016;11(1):e0147601.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute 2011:1–12.

  29. McPheeters ML, Kripalani S, Peterson NB, Idowu RT, Jerome RN, Potter SA, Andrews JC. Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities). Evid Reports/Technology Assessments 2012(208.3):1–475.

  30. Trang NTH, Long NP, Hue TTM, Hung LP, Trung TD, Dinh DN, Luan NT, Huy NT, Hirayama K. Association between nutritional status and dengue infection: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:172.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Basuki PS. A glance at the von Willebrand factor in dengue virus infection. Southeast Asian J Trop Med Public Health. 2003;34(3):559–63.

    CAS  PubMed  Google Scholar 

  32. Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olarn C, Tapaneya-Olarn W, Kowsathit P, Chantarojsiri T. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 2000;31(1):10–4.

    CAS  PubMed  Google Scholar 

  33. Dewi R, Tumbelaka AR, Sjarif DR. Clinical features of dengue hemorrhagic fever and risk factors of shock event. Paediatr Indonesiana. 2006;46(3):144–8.

    Article  Google Scholar 

  34. Kan EF, Rampengan T. Factors associated with shock in children with dengue hemorrhagic fever. Paediatr Indonesiana. 2004;44(5):171–5.

    Article  Google Scholar 

  35. Lovera D, Martinez de Cuellar C, Araya S, Amarilla S, Gonzalez N, Aguiar C, Acuña J, Arbo A. Clinical characteristics and risk factors of dengue shock syndrome in children. Pediatr Infect Dis J. 2016;35(12):1294–9.

    Article  PubMed  Google Scholar 

  36. Tan VPK, Ngim CF, Lee EZ, Ramadas A, Pong LY, Ng JI, Hassan SS, Ng XY, Dhanoa A. The association between obesity and dengue virus (DENV) infection in hospitalised patients. PLoS ONE. 2018;13(7):e0200698.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Junia J, Garna H, Setiabudi D. Clinical risk factors for dengue shock syndrome in children. Paediatr Indonesiana. 2007;47(1):7–11.

    Article  Google Scholar 

  38. Kalayanarooj S, Nimmannitya S. Is dengue severity related to nutritional status? Southeast Asian J Trop Med Public Health. 2005;36(2):378–84.

    PubMed  Google Scholar 

  39. Kurnia B, Suryawan IWB. The association between obesity and severity of Dengue Hemorrhagic Fever in Children at Wangaya General Hospital. Open access Macedonian journal of medical sciences. 2019;7(15):2444–6.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Pichainarong N, Mongkalangoon N, Kalayanarooj S, Chaveepojnkamjorn W. Relationship between body size and severity of dengue hemorrhagic fever among children aged 0–14 years. Southeast Asian J Trop Med Public Health. 2006;37(2):283–8.

    PubMed  Google Scholar 

  41. Putra Y, Arhana BNP, Safitri I, Widiana R. Serum transaminase levels and dengue shock syndrome in children. Paediatr Indonesiana. 2014;54(3):181–5.

    Article  Google Scholar 

  42. Tantracheewathorn T, Tantracheewathorn S. Risk factors of dengue shock syndrome in children. J Med Association Thailand = Chotmaihet thangphaet. 2007;90(2):272–7.

    Google Scholar 

  43. Widiyati MMT, Laksanawati IS, Prawirohartono EP. Obesity as a risk factor for dengue shock syndrome in children. Paediatr Indonesiana. 2013;53(4):187–92.

    Article  Google Scholar 

  44. Widagdo. Blood zinc levels and clinical severity of dengue hemorrhagic fever in children. Southeast Asian J Trop Med Public Health. 2008;39(4):610–6.

    CAS  PubMed  Google Scholar 

  45. Te H, Sriburin P, Rattanamahaphoom J, Sittikul P, Hattasingh W, Chatchen S, Sirinam S, Limkittikul K. Association between nutritional status and dengue severity in thai children and adolescents. PLoS Negl Trop Dis. 2022;16(5):e0010398.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Tan VPK, Ngim CF, Lee EZ, Ramadas A, Pong LY, Ng JI, Hassan SS, Ng XY, Dhanoa A. The association between obesity and dengue virus (DENV) infection in hospitalised patients. PLoS ONE [Electronic Resource]. 2018;13(7):e0200698.

    Article  PubMed  Google Scholar 

  47. Dengue haemorrhagic fever. Diagnosis, treatment, prevention and control. World Health Organization; 1997.

  48. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL, Green S, Vaughn DW, Ennis FA, Endy TP. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007;369(9571):1452–9.

    Article  PubMed  Google Scholar 

  49. Comprehensive guideline for. Prevention and control of dengue and dengue haemorrhagic fever. World Health Organization; 2011.

  50. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjorup I, Lopez-Velez R, Clerinx J, Peyerl-Hoffmann G, Sundoy A, et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis. 2007;195(8):1089–96.

    Article  CAS  PubMed  Google Scholar 

  51. Phuong CX, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT, Thuy TT, Solomon T, Stepniewska K, Wills B, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg. 2004;70(2):172–9.

    Article  PubMed  Google Scholar 

  52. Tsheten T, Clements ACA, Gray DJ, Wangdi K. Dengue risk assessment using multicriteria decision analysis: a case study of Bhutan. PLoS Negl Trop Dis. 2021;15(2):e0009021.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Lima WG, Souza NA, Fernandes SOA, Cardoso VN, Godoi IP. Serum lipid profile as a predictor of dengue severity: a systematic review and meta-analysis. Rev Med Virol. 2019;29(5):e2056.

    Article  PubMed  Google Scholar 

  54. Chuong C, Bates TA, Akter S, Werre SR, LeRoith T, Weger-Lucarelli J. Nutritional status impacts dengue virus infection in mice. BMC Biol. 2020;18(1):106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Laoprasopwattana K, Pruekprasert P, Dissaneewate P, Geater A, Vachvanichsanong P. Outcome of dengue hemorrhagic fever-caused acute kidney injury in thai children. J Pediatr. 2010;157(2):303–9.

    Article  PubMed  Google Scholar 

  56. Gallagher P, Chan KR, Rivino L, Yacoub S. The association of obesity and severe dengue: possible pathophysiological mechanisms. J Infect. 2020;81(1):10–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (109-2314-B-037-126-, 110-2628-B-037-012-, and 111-2628-B-037-006-), Kaohsiung Medical University Research Center Grant (KMU-TC111B01), and Kaohsiung Medical University Hospital (KMUH110-0R24). The funders played no role in the design, interpretation or writing of the manuscript.

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan

    Chao-Ying Chen, Yu-Yao Chiu, Yu-Cheng Chen, Chung-Hao Huang, Wen-Hung Wang, Yen-Hsu Chen & Chun-Yu Lin

  2. School of Medicine, Graduate Institute of Medicine, College of Medicine, Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung, 807, Taiwan

    Yu-Yao Chiu, Yu-Cheng Chen, Chung-Hao Huang, Wen-Hung Wang, Yen-Hsu Chen & Chun-Yu Lin

  3. Institute of Medical Science and Technology, School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, 804, Taiwan

    Wen-Hung Wang & Yen-Hsu Chen

  4. Department of Biological Science and Technology, College of Biological Science and Technology, National Yang Ming Chiao Tung University, HsinChu 100, Taiwan

    Yen-Hsu Chen

  5. Department of Medical Biochemistry and Microbiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

    Chun-Yu Lin

Authors
  1. Chao-Ying Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-Yao Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Cheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chung-Hao Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wen-Hung Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yen-Hsu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chun-Yu Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Chao-Ying Chen, Yu-Yao Chiu, Chung-Hao Huang, Yen-Hsu Chen, and Chun-Yu Lin had made substantial contributions to the conception and study design; Chao-Ying Chen, Yu-Yao Chiu, Yu-Cheng Chen, Wen-Hung Wang, and Chun-Yu Lin collected the data; Chao-Ying Chen, Yu-Yao Chiu, and Chun-Yu Lin analyzed the data; Chao-Ying Chen prepared the manuscript, Yu-Yao Chiu, Yu-Cheng Chen, Chung-Hao Huang, Wen-Hung Wang, Yen-Hsu Chen, and Chun-Yu Lin critical revision of the manuscript; all of the authors read and approved the final version for submission.

Corresponding author

Correspondence to Chun-Yu Lin.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethics approval and consent to participate

As this study was a review of previous published studies, ethical approval or patient consent was waived.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, CY., Chiu, YY., Chen, YC. et al. Obesity as a clinical predictor for severe manifestation of dengue: a systematic review and meta-analysis. BMC Infect Dis 23, 502 (2023). https://doi.org/10.1186/s12879-023-08481-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08481-9

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us